-
Mashup Score: 0Exposure to Cold Outdoor Air Helps Croup Symptoms in Kids - 9 month(s) ago
‘This intervention could be easily used by clinicians,’ researcher says
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Dexamethasone: MedlinePlus Drug Information - 10 month(s) ago
Dexamethasone: learn about side effects, dosage, special precautions, and more on MedlinePlus
Source: medlineplus.govCategories: General Medicine News, Latest HeadlinesTweet-
Dexamethasone is a corticosteroid that is used to relieve inflammation and treat certain forms of arthritis, skin, blood, kidney, eye, thyroid, and intestinal disorders and severe allergies, asthma and cancer. Learn more: https://t.co/SbJTlLsHB7 #Corticosteroid #Dexamethasone https://t.co/w6ZT6zvlun
-
-
Mashup Score: 1Multiple Myeloma the Phase 3 SUCCESSOR-2 Trial MeziKd Verses Kd - 10 month(s) ago
Monique Hartley-Brown, MD, MMSc, from Dana-Farber Cancer Institute, conducted a significant clinical study called SUCCESSOR-2 that focused on the treatment of relapsed/refractory multiple myeloma (RRMM). This Phase 3 study aimed to compare the efficacy and safety of a combination therapy called MeziKd (mezigdomide, …
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🔬 ASCO 2023 Multiple Myeloma 🔬 ➡️ How does the #SUCCESSOR2 phase 3 trial aim to compare the efficacy and safety of #MeziKd versus #carfilzomib and #dexamethasone (#Kd) in patients with RRMM? @DanaFarber #MultipleMyeloma 🔗 https://t.co/WLlGjF3Dk1 https://t.co/uLGbaAOmXr
-
-
Mashup Score: 0phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed iMCD - 11 month(s) ago
TO THE EDITOR:
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
A phase 2 prospective study of #Bortezomib, #Cyclophosphamide, and #Dexamethasone in patients with newly diagnosed #iMCD 👉https://t.co/2LtMDR7DqU @BloodJournal #IL6 https://t.co/ZHgDkHlgNT
-
-
Mashup Score: 0No decreased mortality with high-dose methylprednisolone vs. dexamethasone for COVID-19 - 11 month(s) ago
Higher dose methylprednisolone and low-dose dexamethasone treatments in patients with COVID-19 pneumonia showed similar 28-day mortality rates, according to study results published in European Respiratory Journal.“A protocol of infusive, prolonged, higher dose methylprednisolone did not show major advantages over conventional dexamethasone in COVID-19 pneumonia, confirming the favorable
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Published in @ERSpublications: Higher dose #methylprednisolone and low-dose #dexamethasone treatments in patients with #COVID-19 pneumonia showed similar 28-day mortality rates. https://t.co/V2F8CbZuUW
-
-
Mashup Score: 0
During a Targeted Oncology™ Case-Based Roundtable™ event, Douglas W. Sborov, MD, MS, discussed possible therapy options for a patient who relapsed after receiving bortezomib, lenalidomide, and dexamethasone followed by autologous stem cell transplant.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Douglas W. Sborov, MD, MS, discussed possible therapy options for a patient who relapsed after receiving #bortezomib, #lenalidomide, and #dexamethasone followed by autologous stem cell transplant. Respond to the poll below to join the conversation! https://t.co/spGLBQCUI3 https://t.co/JSeWAR0OJ9
-
-
Mashup Score: 0Daratumumab Plus Lenalidomide and Dexamethasone Demonstrates Survival Benefits for Transplant-Ineligible Patients With Newly Diagnosed MM - 1 year(s) ago
Shaji K. Kumar, MD, discusses the PFS and OS benefit seen with daratumumab added to lenalidomide and dexamethasone vs lenalidomide and dexamethasone alone in transplant-ineligible patients with newly diagnosed multiple myeloma.
Source: HMP Global Learning NetworkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Shaji K. Kumar, MD, presents an updated analysis that continues to support the frontline use of #daratumumab added to #lenalidomide and #dexamethasone in transplant-ineligible patients with newly diagnosed #MultipleMyeloma. Learn more: https://t.co/QZOd1qOUPv @myelomaMD https://t.co/Ko1ZTGn4ep
-
-
Mashup Score: 0
According to a phase 3 study, daratumumab plus lenalidomide and dexamethasone treatment resulted in improved overall survival among patients with relapsed/refractory multiple myeloma, compared to lenalidomide and dexamethasone alone.
Source: HMP Global Learning NetworkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In recent #HematologyNews, #daratumumab plus #lenalidomide and #dexamethasone treatment resulted in improved overall survival among patients with R/R #MultipleMyeloma. Learn more about Dr Dimopoulos' research here: https://t.co/tyW8FcRgOj @thanosdimop https://t.co/6CqYH0zpVQ
-
-
Mashup Score: 0
During a Targeted Oncology case-based roundtable event, Natalie S. Callander, MD, discussed studies that support alternative combination regimens after early relapse on bortezomib, lenalidomide, and dexamethasone for multiple myeloma.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
During a Targeted Oncology case-based roundtable event, @nsc_natalie, MD, discussed studies that support alternative combination regimens after early relapse on #bortezomib, #lenalidomide, and #dexamethasone for #multiplemyeloma. #mmsm | @UWMadison https://t.co/7ewW2QXdge
-
-
Mashup Score: 1
During a Targeted Oncology case-based roundtable event, Natalie S. Callander, MD, discussed studies that support alternative combination regimens after early relapse on bortezomib, lenalidomide, and dexamethasone for multiple myeloma.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
During a Targeted Oncology case-based roundtable event, @nsc_natalie, MD, discussed studies that support alternative combination regimens after early relapse on #bortezomib, #lenalidomide, and #dexamethasone for #multiplemyeloma. #mmsm | @UWMadison https://t.co/7ewW2QXdge
-
"This intervention could be easily used by clinicians." -- Johan Siebert, MD, of Geneva Children's Hospital, on how exposure to outdoor cold air helped improve kids' #croup symptoms when paired with oral #dexamethasone. https://t.co/Ktn4r9cOSE